Table 4.
Article | Experimental Target System | Dosage | Exposure Time | Administration Route | Ameliorative Effects of Resveratrol | |||
---|---|---|---|---|---|---|---|---|
Cd | RV | Cd | RV | Cd | RV | |||
Benvenga et al. (2020) [141] * | MCP-1; CXCL10 | 2 mg/kg | 20 mg/kg | Daily | 14 days | IP | Oral | Follicular area and epithelial height restored to control levels ↓ MCP-1/CCL2 and CXCL10 levels; perifollicular connective tissue |
Benvenga et al. (2021) [142] * | [histological study] | 2 mg/kg | 20 mg/kg | Daily | 14 days | IP | Oral | ↑ follicular thyroid diameters ↓ number of CT-positive cells; TUNEL-positive C cells |
*: in vivo; IP: intraperitoneal; ↑: increase; ↓: decrease/inhibition.